Management of adverse events related to new cancer immunotherapy (immune checkpoint inhibitors)
Author:
Affiliation:
1. Fiona Stanley Hospital, Perth, WA
2. Sir Charles Gairdner Hospital, Perth, WA
3. Princess Margaret Hospital, Perth, WA
Publisher
AMPCo
Subject
General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.5694/mja16.00586
Reference51 articles.
1. Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
2. Enhancing the safety of antibody-based immunomodulatory cancer therapy without compromising therapeutic benefit: Can we have our cake and eat it too?
3. Cancer immunotherapy comes of age
4. Immune checkpoint inhibitors: therapeutic advances in melanoma;Marquez‐Rodas I;Ann Transl Med,2015
5. Management of toxicities of immune checkpoint inhibitors
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Immune checkpoints: new insights into the pathogenesis of thyroid eye disease;Frontiers in Immunology;2024-05-16
2. Neurological autoimmunity in melanoma patients: a comparison between those exposed and non-exposed to immune checkpoint inhibitors;Journal of Neurology;2024-03-11
3. Immunotherapy in Breast Cancer: Situation and Challenge;E3S Web of Conferences;2024
4. Recent advances in immune checkpoint inhibitor-induced type 1 diabetes mellitus;International Immunopharmacology;2023-09
5. Monitoring multidimensional aspects of quality of life after cancer immunotherapy: protocol for the international multicentre, observational QUALITOP cohort study;BMJ Open;2023-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3